Skip to main content
Access Resources

MJFF Publications

21 - 30 of 7370 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • OPEN
    Title: Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer’s disease
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-023-00687-4
    Citation Count: 0
  • OPEN
    Title: Regional differences in synaptic degeneration are linked to alpha-synuclein burden and axonal damage in Parkinson’s disease and dementia with Lewy bodies
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-023-01711-w
    Citation Count: 0
  • OPEN
    Title: Study protocol for the Heads-Up trial: a phase II randomized controlled trial investigating head-up tilt sleeping to alleviate orthostatic intolerance in Parkinson’s Disease and parkinsonism
    Journal Name: BMC Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12883-023-03506-x
    Citation Count: 0
  • OPEN
    Title: Brain structure ages—A new biomarker for multi‐disease classification
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/hbm.26558
    Citation Count: 0
  • OPEN
    Title: Comprehensive analysis of clinical and biological features in Parkinson's disease associated with the LRRK2 G2019S mutation: Data from the PPMI study
    Journal Name: Clinical and Translational Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/cts.13720
    Citation Count: 0
  • OPEN
    Title: Comparative analysis of methods to reduce activation signature gene expression in PBMCs
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-023-49611-2
    Citation Count: 0
  • OPEN
    Title: MAPT Locus in Parkinson’s Disease Patients of Ashkenazi Origin: A Stratified Analysis
    Journal Name: Genes
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3390/genes15010046
    Citation Count: 0
  • OPEN
    Title: Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease
    Journal Name: Nature Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41588-023-01584-8
    Citation Count: 0
  • OPEN
    Title: PyRates—A code-generation tool for modeling dynamical systems in biology and beyond
    Journal Name: PLOS Computational Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pcbi.1011761
    Citation Count: 0
  • OPEN
    Title: Differential LRRK2 Signalling and Gene Expression in WT-LRRK2 and G2019S-LRRK2 Mouse Microglia Treated with Zymosan and MLi2
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells13010053
    Citation Count: 0
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.